A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, Scripps Research and IAVI announced Wednesday.
A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, Scripps Research and IAVI announced Wednesday.
This website, like most media sites, uses small files called cookies to anonymously customize the advertising that you see. Learn more about how we use cookies in our cookie policy.
